Fennec Pharmaceuticals Inc. FENC
Set alert
10.24 USD -0.71 -6.48%
At close · Oct 30
10.24 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
10.14 Day range 10.99
5.77 52-week range 12.78
- YTD
- +32.99%
- 1 year
- +22.93%
- Open
- 10.92
- Prev close
- 10.95
- Mkt cap
- 359.09M
- Vol
- 195.65K
- Avg vol
- 187.92K
- EPS
- -0.12
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.14
- High
- 10.99
- Forward P/E
- 16.78
- Beta
- 0.27
- Short ratio
- 13.06
- Inst. own
- 54.70%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.08
- 200-d avg
- 6.71
- 1y target
- 13.60
2Y chart
Events in this range
- Nov 7, 2024Earnings: -0.21; estimate -0.13; surprise -61.54%
- Dec 17, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (107)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 11, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| RSI: Overbought | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
| RSI: Overbought | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | May 14, 2026 | 5 months ago |
| SMA: Bullish | May 14, 2026 | 5 months ago |
| RSI: Overbought | May 14, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bullish | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 7, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 14, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 10, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 8, 2026 | 6 months ago |
| RSI: Oversold | Mar 30, 2026 | 7 months ago |
| RSI: Oversold | Mar 24, 2026 | 7 months ago |
| SMA: Bearish | Mar 12, 2026 | 7 months ago |
| SMA: Bullish | Mar 11, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| RSI: Overbought | Feb 18, 2026 | 8 months ago |
| SMA: Bullish | Feb 12, 2026 | 8 months ago |
| SMA: Bullish | Feb 6, 2026 | 8 months ago |
| SMA: Bearish | Feb 5, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 28, 2026 | 9 months ago |
| SMA: Bullish | Jan 27, 2026 | 9 months ago |
| SMA: Bearish | Jan 23, 2026 | 9 months ago |
| SMA: Bullish | Jan 22, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 21, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 20, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 6, 2026 | 9 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 26, 2025 | 10 months ago |
| SMA: Bullish | Dec 26, 2025 | 10 months ago |
| SMA: Bearish | Dec 16, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| SMA: Bearish | Dec 5, 2025 | 11 months ago |
| SMA: Bullish | Dec 4, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 2, 2025 | 11 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bearish | Nov 19, 2025 | 11 months ago |
| SMA: Bullish | Nov 17, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 23, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 10, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 25, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Aug 15, 2025 | 1 year ago |
| SMA: Bullish | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 12, 2025 | 1 year ago |
| SMA: Bearish | Jul 31, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 3, 2025 | 1 year ago |
| RSI: Overbought | Jun 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 4, 2025 | 1 year ago |
| RSI: Overbought | May 27, 2025 | 1 year ago |
| RSI: Overbought | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | May 9, 2025 | 1 year ago |
| SMA: Bullish | May 7, 2025 | 1 year ago |
| SMA: Bearish | May 6, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 30, 2025 | 1 year ago |
| SMA: Bullish | Apr 29, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 22, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| SMA: Bullish | Mar 18, 2025 | 1 year ago |
| SMA: Bearish | Mar 17, 2025 | 1 year ago |
| SMA: Bullish | Mar 14, 2025 | 1 year ago |
| SMA: Bearish | Mar 13, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 3, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 28, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 14, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 13, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 12, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 21, 2025 | 1 year ago |
| SMA: Bearish | Jan 17, 2025 | 1 year ago |
| RSI: Overbought | Nov 26, 2024 | 1 year ago |
Key statistics
- Market cap
- 170.35M
- Enterprise value
- 156.10M
- Trailing P/E
- 0.00
- Forward P/E
- 16.78
- PEG ratio
- 0.00
- Price / sales
- 3.45
- Price / book
- 0.00
- EPS (TTM)
- -0.04
- Beta
- 0.27
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -2.30%
- Revenue (TTM)
- 49.35M
- Revenue growth
- 7.00%
- Free cash flow
- -3.40M
- Total cash
- 40.32M
- Total debt
- 32.10M
- Return on equity
- 0.00%
- Shares outstanding
- 27.43M
- Short % of float
- 11.18%
- 50-day average
- 5.08
- 200-day average
- 6.71
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 13.60 +32.8% upside
Now 10.24
- Target (low)
- 12.00
- Target (mean)
- 13.60
- Target (high)
- 15.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy2
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.12.
Financials — quick view
FENC Revenue — quarterly 17.87M
FENC Net income — quarterly 1.97M
FENC EPS — quarterly 0.06
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.13 | -0.21 | -0.08 | -61.54% |
| Aug 13, 2024 | Jun 1, 2024 | 0.06 | -0.20 | -0.26 | -433.33% |
| May 14, 2024 | Mar 1, 2024 | 0.49 | 0.41 | -0.08 | -16.33% |
| Mar 21, 2024 | Dec 1, 2023 | 0.02 | -0.10 | -0.12 | -600.00% |
| Nov 6, 2023 | Sep 1, 2023 | -0.11 | -0.07 | +0.04 | +36.36% |
| Aug 3, 2023 | Jun 1, 2023 | -0.18 | -0.21 | -0.03 | -16.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 22, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Aug 14, 2024 | Craig-Hallum | main | Buy | Buy |
| May 15, 2024 | Craig-Hallum | main | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Apr 4, 2024 | HC Wainwright & Co. | main | Buy | Buy |
About Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- fennecpharma.com
News
- Adherex Technologies Inc. (NASDAQ:FENC) Stock Now Rated “Moderate Buy” by Sell-Side Analysts
- Adherex Technologies (NASDAQ:FENC) and SCYNEXIS (NASDAQ:SCYX) Financial Survey
- Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026
- HC Wainwright & Co. Reiterates Buy on Fennec Pharmaceuticals, Maintains $16 Price Target
- B. Riley Securities Reiterates Buy on Fennec Pharmaceuticals, Raises Price Target to $18
- Wedbush Maintains Outperform on Fennec Pharmaceuticals, Raises Price Target to $16
- Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?
- Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call Transcript
- Adherex Technologies Q2 Earnings Call Highlights
- Adherex Technologies Inc. (FENC) Beats Q2 Earnings and Revenue Estimates
Your note
Sign in to keep a note on FENC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANDRADE ROBERT C | Chief Financial Officer | Stock Award(Grant) | Dec 1, 2024 | 128,423 |
| HAIGH ADRIAN J | Chief Operating Officer | Conversion of Exercise of derivative security | Apr 21, 2024 | 0 |
| ISLAM KHALID | Director | Conversion of Exercise of derivative security | Nov 15, 2023 | 213,825 |
| RALLIS CHRISTOPHER ANIGERON | Director | Conversion of Exercise of derivative security | Dec 1, 2024 | 52,214 |
| RAYKOV ROSTISLAV CHRISTOV | Director | Sale | Dec 4, 2024 | 66,432 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Southpoint Capital Advisors Lp | 14.84% | 4,077,214 | 25.32M | Sep 29, 2024 |
| Sonic Gp LLC | 8.76% | 2,407,357 | 14.95M | Sep 29, 2024 |
| Solas Capital Management, LLC | 7.00% | 1,923,536 | 11.95M | Sep 29, 2024 |
| DG Capital Management, LLC | 5.54% | 1,522,204 | 9.45M | Sep 29, 2024 |
| Blackrock Inc. | 4.48% | 1,229,477 | 7.64M | Sep 29, 2024 |
| Vanguard Group Inc | 3.81% | 1,047,891 | 6.51M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.19% | 876,208 | 5.44M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.04% | 559,371 | 3.47M | Oct 30, 2024 |
| Fidelity Small Cap Index Fund | 0.88% | 241,018 | 1.50M | Aug 30, 2024 |
| iShares Russell 2000 Value ETF | 0.60% | 165,510 | 1.03M | Oct 30, 2024 |
| Vanguard Russell 2000 Index Fund | 0.34% | 94,580 | 587.34K | Aug 30, 2024 |
| Schwab Capital Trust-Small Cap Index Fund | 0.20% | 55,452 | 344.36K | Jul 30, 2024 |